Commercial Launch Planning

is one of the most challenging and “need to get right on first try” activity that life science companies will engage in.

Axelleron’s “Out of the Box” Launch Excellence Program offers a solution that empowers teams to collaborate remotely, reduce communication barriers, react to data, and progress faster by running a customized launch playbook systematically.

Late Stage Portfolio Management

is a dynamic decision process with regular updates, revisions, and prioritization of pipeline assets. There is uncertainty and constant changes in the information flow.

Axelleron provides teams with a well-defined process enabling a sustainable and enhanced approach, efficient use of time and resources, and improved synergies among the teams and portfolio projects.



has to be an enterprise-driven and transparent process to ensure accuracy and credibility.

Axelleron lays out an approach to ensure linkage between portfolio or deal forecasts, long term and short term commercial forecasts. The roles and responsibilities are clearly articulated and the process is sure to improve synergies, drive compliance to PCAOB standards, and limit exposure to potential analyst backlash for misleading the market.

Post Launch Analytics

is about what needs to measured and when. Getting this right is a crucial aspect of any successful commercialization.

With Axelleron’s post launch analytics process, we removed the guess work. Our defined process maps out what needs to be measured, when is the ideal time to review this data, and which function is responsible for compiling this information. An efficient and tested approach to ensure you have full view and control on your product performance post launch.